Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATROPINE: Anesthetic Strategy During Organ Procurement in Brain Dead Donors
NCT07166991Phase 3Recruiting
- Sponsor
- CHU Grenoble Alpes
- Start
- Feb 2026
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sevoflurane in brain death, sponsored by CHU Grenoble Alpes. Started Feb 2026; status: recruiting.
02
Drugs
sevoflurane
03
Conditions
brain death
Beyond the preview
Go deeper on NCT07166991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07166991.